Clinical Trial Update: Implementing Oral (Event-driven and Daily) and Long-acting Pre-Exposure Prophylaxis in Mobile Men in Sub-Saharan Africa [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating oral (event-driven and daily) and long-acting pre-exposure prophylaxis in mobile men in Sub-Saharan Africa for HIV prevention.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Snippet

Sponsor: MRC/UVRI and LSHTM Uganda Research Unit | Conditions: HIV | Phase 3 | Status: NOT_YET_RECRUITING